Results
1 -
10 of
68
(Click
here to explore results)
Designing Multi-Target Drugs, Chapter 14 Discovery of HDAC-Inhibiting Multi-Target Inhibitors . Xiong Cai, Changgeng Qian
, 2012
, Pages 221-242
The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 8 Chemical Probes for Kinases . Xiaoyun Lu, Jeff B. Smaill, Ke Ding
, 2021
, Pages 182-213
Kinase Drug Discovery, Chapter 5 Kinase Mutations and Resistance in Cancer . Jack Andrew Bikker
, 2012
, Pages 126-160
Designing Multi-Target Drugs, Chapter 11 Combination Agents Versus Multi-Targeted Agents – Pros and Cons . Jose G. Monzon, Janet Dancey
, 2012
, Pages 155-180
Conference on Drug Design and Discovery Technologies, Design and Synthesis of Some Novel Erlotinib Derivatives as Potential EGFR Kinase Inhibitors . V. Ajeesh, S. Shubham, M. Ruchi
, 2020
, Pages 95-98
Kinase Drug Discovery: Modern Approaches, CHAPTER 11 The Importance of Kinase Mutations in Cancer Drug Discovery . Richard A. Ward, Frederick W. Goldberg
, 2019
, Pages 281-312
MicroRNAs in Diseases and Disorders: Emerging Therapeutic Targets, CHAPTER 14 Strategies for Safe and Targeted Delivery of MicroRNA Therapeutics . Sunghyun (Sander) Myoung, Andrea L. Kasinski
, 2019
, Pages 386-415
The Chemistry and Bioactive Components of Turmeric, CHAPTER 12 Biological Activities of Non-curcuminoids . Swee Keong Yeap, Wan Yong Ho
, 2021
, Pages 249-292
Kinase Drug Discovery: Modern Approaches, CHAPTER 4 Covalent Inhibition of Kinases . Gerjan de Bruin, Tjeerd Barf
, 2019
, Pages 61-96
Kinase Drug Discovery: Modern Approaches, CHAPTER 6 The Design of Brain Penetrant Kinase Inhibitors . Sarah E. Skerratt, R. Ian Storer
, 2019
, Pages 128-180